Clobazam therapy of refractory epilepsy in tuberous sclerosis complex

Epilepsy Research

Volumn 104, Issue 3, 2013, Pages 269-274

  Jennesson, Melanie ^a   van Eeghen, Agnies M ^a   Caruso, Paul A ^a   Paolini, Jan L ^a   Thiele, Elizabeth A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anticonvulsants; Clobazam; Drug therapy; Epilepsy

Indexed keywords

CLOBAZAM; TUBERIN;

ADOLESCENT; AGGRESSIVENESS; ARTICLE; ATAXIA; AUTISM; BEHAVIOR DISORDER; BRAIN SURGERY; CHILD; COGNITIVE DEFECT; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; EPILEPSY; EVENING DOSAGE; FEMALE; HUMAN; HYPERSALIVATION; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD DISORDER; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SPEECH DISORDER; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT RESPONSE; TUBEROUS SCLEROSIS; VAGUS NERVE STIMULATION;

ADOLESCENT; ANTICONVULSANTS; BENZODIAZEPINES; CHILD; CHILD, PRESCHOOL; EPILEPSY; HUMANS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 84877002859     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.10.010     Document Type: Article

References (28)

1. Allen J.W., Jawad S., Oxley J., Trimble M. Development of tolerance anticonvulsant effect of clobazam. J. Neurol. Neurosurg. Psychiatry 1985, 48:284-285.
2. Au K.S., Williams A.T., Roach E.S., Batchelor L., Sparagana S.P., Delgado M.R., Wheless J.W., Baumgartner J.E., Roa B.B., Wilson C.M., Smith-Knuppel T.K., Cheung M.Y., Whittemore V.H., King T.M., Northrup H. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet. Med. 2007, 9:88-100.
3. Canadian Clobazam Cooperative Group Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Epilepsia 1991, 32:407-416.
4. Canadian Study Group for Childhood Epilepsy Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998, 39:952-959.
5. Chapman A.G., Horton R.W., Meldrum B.S. Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy. Epilepsia 1978, 19:293-299.
6. Chu-Shore C.J., Major P., Camposano S., Muzykewicz D., Thiele E.A. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010, 51:1236-1241.
7. Collins J.J., Tudor C., Leonard J.M., Chuck G., Franz D.N. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. J. Child Neurol. 2006, 21:53-57.
8. Corman C., Guberman A., Benavente O. Clobazam in partial status epilepticus. Seizure 1998, 7:243-247.
9. Dulac O., Figueroa D., Rey E., Arthuis M. Monotherapy with clobazam in epilepsies in children. Presse Med. 1983, 12:1067-1069.
10. Franz D.N., Tudor C., Leonard J. Topiramate as therapy for tuberous sclerosis complex-associated seizures. Epilepsia 2000, 41:87.
11. Franz D.N., Tudor C., Leonard J., Egelhoff J.C., Byars A., Valerius K., Sethuraman G. Lamotrigine therapy of epilepsy in tuberous sclerosis. Epilepsia 2001, 42:935-940.
12. Gastaut H., Low M.D. Antiepileptic properties of clobazam, a 1,5-benzodiazepine, in man. Epilepsia 1979, 20:437-446.
13. Kalra V., Seth R., Mishra D., Saha N.C. Clobazam in refractory childhood epilepsy. Indian J. Pediatr. 2010, 77:263-266.
14. Kinoshita M., Ikeda A., Begum T., Terada K., Shibasaki H. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB. J. Neurol. Sci. 2007, 263:44-48.
15. Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G., Moshe S.L., Perucca E., Wiebe S., French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077.
16. Michael B., Marson A.G. Clobazam as an add-on in the management of refractory epilepsy. Cochrane Database Syst. Rev. 2008, 16:CD004154.
17. Mills J.K., Lewis T.G., Mughal K., Ali I., Ugur A., Whitehouse W.P. Retention rate of clobazam, topiramate and lamotrigine in children with intractable epilepsies at 1 year. Seizure 2011, 20:402-405.
18. Montenegro M.A., Arif H., Nahm E.A., Resor S.R., Hirsch L.J. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center. Clin. Neuropharmacol. 2008, 31:333-338.
19. Munn R., Farrell K. Open study of clobazam in refractory epilepsy. Pediatr. Neurol. 1993, 9:465-469.
20. Pellock J.M., Hrachovy R., Shinnar S., Baram T.Z., Bettis D., Dlugos D.J., Gaillard W.D., Gibson P.A., Holmes G.L., Nordl D.R., O'Dell C., Shields W.D., Trevathan E., Wheless J.W. Infantile spasms: a U.S. consensus report. Epilepsia 2010, 51:2175-2189.
21. Remy C. Clobazam in the treatment of epilepsy: A review of the literature. Epilepsia 1994, 35(Suppl 5):S88-91.
22. Riss J., Cloyd J., Gates J., Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol. Scand. 2008, 118:69-86.
23. Roach E.S., Gomez M.R., Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J. Child Neurol. 1998, 13:624-628.
24. Sheth R.D., Goulden K.J., Ronen G.M. Aggression in children treated with clobazam for epilepsy. Clin. Neuropharmacol. 1994, 17:332-337.
25. Shimizu H., Kawasaki J., Yuasa S., Tarao Y., Kumagai S., Kanemoto K. Use of clobazam for the treatment of refractory complex partial seizures. Seizure 2003, 12:282-286.
26. Silva R.C., Montenegro M.A., Guerreiro C.A., Guerreiro M.M. Clobazam as add-on therapy in children with epileptic encephalopathy. Can. J. Neurol. Sci. 2006, 33:209-213.
27. Thiele E.A. Managing epilepsy in tuberous sclerosis complex. J. Child Neurol. 2004, 19:680-686.
28. Wildin J.D., Pleuvry B.J., Mawer G.E., Onon T., Millington L. Respiratory and sedative effects of clobazam and clonazepam in volunteers. Br. J. Clin. Pharmacol. 1990, 29:169-177.